Pallas Capital Advisors LLC Viking Therapeutics, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 21,240 shares of VKTX stock, worth $741,063. This represents 0.04% of its overall portfolio holdings.
Number of Shares
21,240
Previous 21,405
0.77%
Holding current value
$741,063
Previous $1.36 Million
36.97%
% of portfolio
0.04%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding VKTX
# of Institutions
469Shares Held
63.2MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$210 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$163 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$73.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$65.4 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.68B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...